Bicarbonate dialysis, unlike acetate-free biofiltration, triggers mediators of inflammation and apoptosis in endothelial and smooth muscle cells

Journal of Nephrology

Volumn 19, Issue 1, 2006, Pages 57-64

  Amore, Alessandro ^a   Cirina, Paola ^a   Bonaudo, Roberto ^a   Conti, Giovanni ^a   Chiesa, Monica ^a   Coppe, Rosanna ^a  

^a REGINA MARGHERITA CHILDREN S HOSPITAL   (Italy)

Author keywords

Acetate free biofiltration; Apoptosis; Bicarbonate hemodialysis; Biocompatibility; COX 2; Dialysates; Inflammation in dialysis; Nitric oxide synthase; p53

Indexed keywords

ARGININE; CITRULLINE; CYCLOOXYGENASE 2; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; NITRIC OXIDE SYNTHASE; PROTEIN P53;

ANALYSIS OF VARIANCE; APOPTOSIS; ARTICLE; BIOCOMPATIBILITY; BIOFILTRATION; BLOOD SAMPLING; CELL ACTIVATION; CELL FUNCTION; CELL INTERACTION; CIRCULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIALYSATE; ENDOTHELIUM CELL; ENZYME ACTIVITY; EX VIVO STUDY; HEMODIALYSIS; HUMAN; INCUBATION TIME; INFLAMMATION; INTERMETHOD COMPARISON; LYMPHOCYTE; MEDIATOR RELEASE; MONOCYTE; PROCESS MODEL; PROTEIN SECRETION; PROTEIN SYNTHESIS; RNA TRANSCRIPTION; SMOOTH MUSCLE FIBER;

APOPTOSIS; BICARBONATES; BIOLOGICAL MARKERS; CELLS, CULTURED; CYCLOOXYGENASE 2; DIALYSIS SOLUTIONS; ENDOTHELIUM, VASCULAR; GENE EXPRESSION; HEMODIAFILTRATION; HUMANS; INFLAMMATION; MEMBRANE PROTEINS; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE SYNTHASE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33645469745     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Excerpts from United States Renal Data System 1999 Annual data report. Am J Kidney Dis 1999; 34 (supp] 1): S1-176.
2. London GM, Drueke TB. Atherosclerosis and arteriosclerosis in chronic renal failure. Kidney Int 1997; 51: 1678-95.
3. Hakim RM. Influence of the dialysis membrane on outcome of ESRD patients. Am J Kidney Dis 1998; 32 (suppl 4): S71-5.
4. Zimmermann J, Herrlinger S, Pruy A. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999; 55: 648-58.
5. Ikizler TA, Wingard RL, Harvell J, Shyr Y, Hakim RM. Association of morbidity with markers of nutrition and inflammation in chronic hemodialysis patients: a prospective study. Kidney Int 1999; 55: 1945-51.
6. Libby P. Changing concepts of atherogenesis. J Intern Med 2000; 247: 349-58.
7. Schmitz G, Herr AS, Rothe G. T-lymphocytes and monocytes in atherogenesis. Herz 1998; 23: 168-77.
8. Hansson GK, Libby P, Schonbeck U, Yan ZQ. Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ Res 2002; 23: 281-91.
9. Amore A, Bonaudo R, Ghigo D, Arese M, Costamagna C, Cirina P, Gianoglio B, Perugini L, Coppo R. Enhanced production of nitric oxide by blood-dialysis membrane interaction. J Am Soc Nephrol 1995; 6: 1278-83.
10. Amore A, Cirina P, Mitola S, Peruzzi L, Bonaudo R, Gianoglio B, Coppo R. Acetate intolerance is mediated by enhanced synthesis of nitric oxide by endothelial cells. J Am Soc Nephrol 1997; 8: 1431-6.
11. Bussolino F, De Rossi M, Sica A, Colotta F, Wang JM, Bocchietto E, Padura IM, Bosia A, DeJana E, Mantovani A. Murine endothelioma cell lines transformed by polyoma middle T oncogene as target for and producers of cytokines. J Immunol 1993; 147: 2122-9.
12. Amore A, Emancipator SN, Cirina P, Conti G, Ricotti E, Bagheri N, Coppo R. Nitric oxide mediates cyclosporine-induced apoptosis in cultured renal cells. Kidney Int 2000; 57: 1549-59.
13. Amore A, Cirina P, Conti G, Cerutti F, Bagheri N, Emancipator SN, Coppo R. Amadori configurated albumin induces nitric-oxide-dependent apoptosis of endothelial cells: a possible mechanism of diabetic vasculopathy. Nephrol Dial Transplant 2004; 19: 53-60.
14. Kunz D, Muhl H, Walker G, Pfeilschifter J. Two distinct signalling pathways trigger the expression of inducible nitric oxide synthase in rat mesangial cells. Proc Natl Acad Sci USA 1994; 91: 5387-91.
15. Alderton WK, Cooper CE, Knowles RG. Nitric oxide synthases: structure, function and inhibition. Biochem J 2001; 357: 593-615.
16. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathopyhsiology, and pharmacology. Pharmacol Rev 1999; 43: 109-42.
17. Amore A, Cirina P, Mitola S, Peruzzi L, Gianoglio B, Rabbone I, Sacchetti C, Cerutti F, Grillo C, Coppo R. Nonenzymatically glycated albumin (Amadori adducts) enhances nitric oxide synthase activity and gene expression in endothelial cells. Kidney Int 1997; 51: 27-35.
18. Nishiol E, Watanabe Y. Nitric oxide donor-induced apoptosis in smooth muscle cells is modulated by protein kinase A. Eur J Pharmacol 1997; 339: 245-51.
19. Sandau K, Pfeilschifter J, Brune B. Nitric oxide and superoxide induced p53 and Bax accumulation during mesangial cell apoptosis. Kidney Int 1997; 52: 378-86.
20. Leonard SS, Harris GK, Shi X. Metal-induced oxidative stress and signal transduction. Free Radic Biol Med 2004; 37: 1921-42.
21. El-Deiry WS, Harper JW, O'Conor PM. WAF1/CP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 1994; 54: 1169-74.
22. Xiong Y, Hannon GJ, Zhang H. p21 is a universal inhibitor of cyclin kinases. Nature 1993; 366: 701-4.
23. Waga S, Hannon GJ, Beach D. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 1994; 369: 574-8.
24. Hinz B, Brune K. Cyclooxygenase-2 - 10 years later. J Pharmacol Exp Ther 2002; 300: 367-75.
25. Marcinkiewicz J. Regulation of cytokine production by eicosanoids and nitric oxide. Arch Immunol Ther Exp 1997; 45: 163-7.
26. Clancy R, Varenika B, Huang W, Ballou L, Attur M, Amin AR, Abramson SB. Nitric oxide synthase/COX cross-talk: nitric oxide activates COX-1 but inhibits COX-2-derived prostaglandin production. J Immunol 2000; 165: 1582-7.
27. Perz-Sala D, Lamas S. Regulation of cyclooxygenase-2 expression by nitric oxide in cells. Antioxid Redox Signal 2001; 3: 231-48.
28. Zahner G, Wolf G, Ayoub M, Reinking R, Panzer U, Shankland SJ, Stahl RA. Cyclooxigenase-2 overexpression inhibits platelets-derived growth factor-induced mesangial cell proliferation through induction of the tumor suppressor Gene p53 and the cyclin-dependent kinase inhibitors p21waf-1/cip-1 and p27kip-1. J Biol Chem 2002; 227: 9763-71.
29. Backer CS, Hall RJ, Evans TJ, Pomerance A, Maclouf J, Creminon C, Yacoub MH, Polak JM. Cyclooxigenase-2 is widely expressed in atherosclerotic lesions affecting native and transplanted human coronary arteries and colocalizes with inducible nitric oxide synthase and nitrotyrosine particularly in macrophages. Arterioscler Thromb Vasc Biol 1999; 19: 646-55.
30. Schönbeck U, Sukhova GK, Graber P, Coulter S, Libby P. Augmented expression of cyclooxigenase-2 in human atherosclerotic lesions. Am J Pathol 1999; 155: 1281-91.
31. Stemme V, Swedenborg J, Claesson H, Hansson GK. Expression of cyclo-oxigenase-2 in human atherosclerotic carotid arteries. Eur J Vasc Endovasc Surg 2000; 20: 146-52.
32. Port FK, VanDeKerkhove KM, Kunkel SL, Kluger MJ. The role of dialysate in the stimulation of interleukin-1 produced during clinical hemodialysis. Am J Kidney Dis 1987; 10: 118-22.
33. Lonnemann G, Behrne TC, Lenzner B. Permeability of dialyzer membranes to TNF alpha-inducing substances derived from water bacteria. Kidney Int 1992; 42: 61-8.
34. Todeschini M, Macconi D, Fernandez NG, Ghilardi M, Anabaya A, Binda E, Morigi M, Cattaneo D, Perticucci E, Remuzzi G, Noris M. Effect of acetate-free biofiltration and bicarbonate hemodialysis on neutrophilactivation. Am J Kidney Dis 2002; 40: 783-93.
35. Epperlein MM, Nourooz-Zadeh J, Jayasena SD, Hothersall JS, Noronha-Dutra A, Neild GH. Nature and biological significance of free radicals generated during bicarbonate hemodialysis. J Am Soc Nephrol 1998; 9: 457-63.